DrugCite
Search

MAXIMO II CRT D

Adverse Events
Reference
Comments

Most Common Maximo Ii Crt D Reports to the FDA

What are the most common Maximo Ii Crt D reports to the FDA?

Premature Discharge Of Battery
84
Low Battery
31
No Known Device Problem
26
Oversensing
10
No Code Available
9
Failure To Pace Or Properly Pace
8
Inappropriate Shock
7
Mechanical Issue
7
High Impedance
6
No Information
6
Defective Item
5
Show More Show More
Premature Elective Replacement Indi...
5
Reset Issue
5
Artifact
4
Device Remains Activated
4
Failure To Capture
4
Power Source Issue
4
Communication Or Transmission Issue
3
Connection Issue
3
Failure To Interrogate
3
Incorrect Measurement
3
Loose Or Intermittent Connection
3
Electro-magnetic Interference (emi)
2
Failure To Shock Or Properly Shock
2
Output Above Specifications
2
Patient-device Incompatibility
2
Unable To Obtain Readings
2
Battery Issue
1
Capturing Issue
1
Delayed Charge Time
1
Device Expiration Issue
1
Failure To Convert Rhythm
1
High Sensing Threshold
1
No Pacing
1
Other (for Use When An Appropriate ...
1
Output Issue
1
Shock Counters, Resetting Of
1
Therapeutic Or Diagnostic Output Fa...
1

Devices Similar to Maximo Ii Crt D

Maximo Ii Crt D Scientific Publications

What Maximo Ii Crt D safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Maximo Ii Crt D. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Maximo Ii Crt D.